BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 253 filers reported holding BIONTECH SE in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,359,213 | +10.2% | 76,944 | +9.4% | 0.00% | 0.0% |
| Q2 2023 | $7,588,127 | +6.0% | 70,306 | +22.3% | 0.00% | 0.0% |
| Q1 2023 | $7,158,664 | -6.9% | 57,467 | +12.3% | 0.00% | 0.0% |
| Q4 2022 | $7,688,711 | -5.6% | 51,183 | -15.2% | 0.00% | -33.3% |
| Q3 2022 | $8,142,000 | +2.3% | 60,362 | +13.1% | 0.00% | +50.0% |
| Q2 2022 | $7,958,000 | -29.8% | 53,378 | -19.7% | 0.00% | -33.3% |
| Q1 2022 | $11,332,000 | -48.2% | 66,442 | -21.8% | 0.00% | -40.0% |
| Q4 2021 | $21,895,000 | +1.0% | 84,929 | +7.0% | 0.01% | 0.0% |
| Q3 2021 | $21,669,000 | +31.3% | 79,374 | +7.7% | 0.01% | +25.0% |
| Q2 2021 | $16,504,000 | +137.7% | 73,716 | +15.9% | 0.00% | +100.0% |
| Q1 2021 | $6,943,000 | -10.2% | 63,582 | -53.2% | 0.00% | +100.0% |
| Q4 2020 | $7,733,000 | +881.3% | 135,977 | +1094.6% | 0.00% | – |
| Q3 2020 | $788,000 | +17.8% | 11,383 | -61.4% | 0.00% | – |
| Q2 2020 | $669,000 | +3245.0% | 29,455 | +8798.8% | 0.00% | – |
| Q1 2020 | $20,000 | – | 331 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |